Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225.4 USD | -2.83% | +0.22% | -12.88% |
09:44am | Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA | MT |
Jun. 06 | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.88% | 32.82B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
+64.13% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+3.60% | 9.06B | |
-16.26% | 7.46B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating